Adverse Drug Events
Conditions
Keywords
Drug-Related Problems, Clinical Pharmacist, Elderly, Diabetes
Brief summary
Drug-Related Problems (DRP) are a variety of events or circumstances that can interfere with the expected results of a treatment. They may be due to the drug itself, its association with other treatments, its incompatibility with the patient, its misuse... When these situations result in harm, they are referred to as adverse drug events (ADEs). DRP and particularly ADE represent a major public health problem in healthcare institutions because of their impact on morbidity and health costs. DRPs are largely preventable and actions can be set up to detect and correct them. It is in this context that clinical pharmacy has expanded, with the development of new activities to help secure drug management. In our institution, the investigators have implemented several activities in different care services, including * medication reconciliation, * an ADE detection. These activities have interesting and encouraging results in terms of impact on the prevention of DRP. However, they can only be carried out on a limited number of patients, depending on the pharmaceutical resources available. The investigators therefore need tools to prioritize our activities on the most at-risk patients. In this study, the investigators seek to identify DRP risk factors and develop DRP risk scores, with the objective to improve the detection and even prevention of DRP. Translated with www.DeepL.com/Translator (free version)
Interventions
Detection of Adverse Drug Events or Drug-Related Problems
Sponsors
Study design
Eligibility
Inclusion criteria
\- Patients aged above 18 years old, admitted to the emergency department or hospital
Exclusion criteria
* Patients presenting acute psychological disturbance * Patients that did not agree to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems | 1 day | Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number and type of Adverse Drug Events and Drug-Related Problems | 1 day | Number and type of Adverse Drug Events and Drug-Related Problems |
Countries
France